This pilot study evaluates a pharmacist-led medication adherence intervention and Medisafe mobile application among patients with newly diagnosed cancer and multimorbidity. Thirty participants will be randomized to intervention or usual care to assess feasibility, acceptability, usability, and preliminary efficacy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
30
Training and use of Medisafe application for medication adherence support.
Comprehensive medication review and education by pharmacist.
Feasibility, as measured by number of participants recruited
recruitment of 30 patients in 6 months
Time frame: 6 months
Feasibility, as measured by screening to enrollment ratio
screen to enrollment ratio \>30%
Time frame: from screening to enrollment, approximately 2 weeks
Feasibility, as measured by completion rate of the comprehensive medication review
60% completion of the comprehensive medication review
Time frame: from enrollment to completion of 6 month follow up
Feasibility, as measured by completion rate of the adherence log
80% completion of the adherence log at 3 months
Time frame: 3 months
Feasibility, as measured by completion rate of the adherence log
60% completion of the adherence log at 6 months
Time frame: 6 months
Acceptability, as measured by Acceptability of Intervention Measure (AIM)
Time frame: 3 months, 6 months
Usability, as measured by the System Usability Score of the Medisafe application
The SUS is a 10-item questionnaire that has been validated for mobile applications.
Time frame: 3 months, 6 months
Patient-centeredness, as measured by the Patient-Centered Care Questionnaire (PCCQ)
PCCQ assesses the extent to which care delivery aligns with the core principles of patient-centered care and includes dimensions like respect for patient preferences, emotional support, and physical comfort.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 3 months
Patient-centeredness, as measured by the Patient-Centered Outcomes Questionnaire (PCOQ)
PCOQ measures whether healthcare interventions address the issues patients consider most important. It emphasizes outcomes that matter most to patients, such as symptom relief, quality of life, and emotional well-being.
Time frame: 3 months
Quality of life, as measured by the 36-item Short Form Survey (SF-36)
Time frame: Baseline, 3 months, 6 months
Financial well-being, as measured by the Comprehensive Score for Financial Toxicity
Time frame: Baseline, 3 months, 6 months
Patient activation, as measured by the Patient Activation Measure (PAM)
PAM evaluates the patient's knowledge, skill, and confidence in managing their health, focusing on how engaged patients are in their care and whether they feel empowered in decision-making processes.
Time frame: Baseline, 3 months, 6 months
Adherence, as measured by the Adherence to Refills Medication Scale (ARMS)
Adherence to Refills Medication Scale (ARMS), a validated survey on barriers to adherence, and logs obtained from the Medisafe mobile application.
Time frame: Baseline, 3 months, 6 months